Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer
暂无分享,去创建一个
I. Shmulevich | Wei Zhang | A. Sood | Da Yang | F. Xue | D. Mezzanzanica | M. Bagnoli | Yan Sun | Fei Guo | Ke-Xin Chen | Bao‐cun Sun | F. Guo
[1] Yanhong Shi,et al. MicroRNAs: Small molecules with big roles in neurodevelopment and diseases , 2015, Experimental Neurology.
[2] Wei Zhang,et al. MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer , 2015, The Journal of pathology.
[3] Jun Ma,et al. miR‐101 Acts as a Tumor Suppressor by Targeting Kruppel‐like Factor 6 in Glioblastoma Stem Cells , 2015, CNS neuroscience & therapeutics.
[4] Leonid Peshkin,et al. A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis , 2014, Cell.
[5] Y. Zeng,et al. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] Fei-Fei Liu,et al. MicroRNAs in nasopharyngeal carcinoma , 2014, Chinese journal of cancer.
[7] R. Bamezai,et al. MiR-101 Induces Senescence and Prevents Apoptosis in the Background of DNA Damage in MCF7 Cells , 2014, PloS one.
[8] J. Haier,et al. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. , 2014, World journal of gastroenterology.
[9] M. Barbareschi,et al. MicroRNAs as lung cancer biomarkers. , 2014, World journal of clinical oncology.
[10] Yuan Cao,et al. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway. , 2014, Molecular medicine reports.
[11] Jeffrey K. Mito,et al. MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. , 2014, The Journal of clinical investigation.
[12] Jing Cai,et al. miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer , 2014, Tumor Biology.
[13] Xiao-jing Yang,et al. A novel AP-1/miR-101 regulatory feedback loop and its implication in the migration and invasion of hepatoma cells , 2014, Nucleic acids research.
[14] O. Fortunato,et al. Therapeutic Use of MicroRNAs in Lung Cancer , 2014, BioMed research international.
[15] F. Huang,et al. miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells. , 2014, International journal of clinical and experimental pathology.
[16] Tadashi Kimura,et al. The Role of MicroRNAs in Ovarian Cancer , 2014, BioMed research international.
[17] T. Vondriska,et al. Mesenchymal-endothelial-transition contributes to cardiac neovascularization , 2014, Nature.
[18] Wenjing Pan,et al. MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2 , 2014, Tumor Biology.
[19] Liqiong Zeng,et al. miR-101 Inhibits the G1-to-S Phase Transition of Cervical Cancer Cells by Targeting Fos , 2014, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[20] N. Shen,et al. Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation , 2014, Cell Death and Disease.
[21] Jeffrey T. Chang,et al. A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype , 2014, Breast Cancer Research.
[22] Chaoqian Xu,et al. miR-101 Promotes Breast Cancer Cell Apoptosis by Targeting Janus Kinase 2 , 2014, Cellular Physiology and Biochemistry.
[23] A. Schrader,et al. Clinical significance of epithelial-mesenchymal transition , 2014, Clinical and Translational Medicine.
[24] Ilya Shmulevich,et al. MiR‐506 suppresses proliferation and induces senescence by directly targeting the CDK4/6–FOXM1 axis in ovarian cancer , 2014, The Journal of pathology.
[25] Weishan Zhang,et al. MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2. , 2014, Oncology reports.
[26] Hiroko Oshima,et al. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1 , 2014, Gut.
[27] J. Eun,et al. MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma , 2014, Oncogene.
[28] Hong-Fei Wu,et al. A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer , 2014, PloS one.
[29] Fang Liu,et al. miR-92a family and their target genes in tumorigenesis and metastasis. , 2014, Experimental cell research.
[30] S. Shen,et al. MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer , 2014, Clinical and Translational Oncology.
[31] Wei Zhang,et al. miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma , 2014, Oncology reports.
[32] J. Li,et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer , 2014, Oncogene.
[33] Xiang-ming Ding,et al. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT) , 2014, Chinese journal of cancer.
[34] A. Pertsemlidis,et al. A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation , 2014, Oncotarget.
[35] Yongjie Zhang,et al. TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1. , 2014, Molecular bioSystems.
[36] Zhe Wang,et al. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation , 2014, Oncogene.
[37] X. Chen,et al. Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition , 2013, Oncogene.
[38] Bo Hu,et al. Noncoding RNAs in cancer and cancer stem cells , 2013, Chinese journal of cancer.
[39] Eshel Ben-Jacob,et al. MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.
[40] E. Li,et al. Down‐regulated desmocollin‐2 promotes cell aggressiveness through redistributing adherens junctions and activating beta‐catenin signalling in oesophageal squamous cell carcinoma , 2013, The Journal of pathology.
[41] Qinghe Zhang,et al. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. , 2013, Gene.
[42] R. Postier,et al. DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer , 2013, PloS one.
[43] K. Kalland,et al. MiR‐182 and miR‐203 induce mesenchymal to epithelial transition and self‐sufficiency of growth signals via repressing SNAI2 in prostate cells , 2013, International journal of cancer.
[44] Xu Gao,et al. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. , 2013, Cancer letters.
[45] Rende Guo,et al. MicroRNA‐182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas , 2013, Journal of cellular biochemistry.
[46] L. Qin,et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] A. G. de Herreros,et al. PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation , 2013, PLoS genetics.
[48] S. Shankar,et al. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. , 2013, Neuro-oncology.
[49] Xiangyi Zheng,et al. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. , 2013, Biochemical and biophysical research communications.
[50] W. Park,et al. miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines , 2013, PloS one.
[51] Stephanie Ma,et al. Clinical implications of microRNAs in liver cancer stem cells , 2013, Chinese journal of cancer.
[52] M. Hou,et al. Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. , 2013, Biochimica et biophysica acta.
[53] Xiaofei Xu,et al. The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. , 2013, The international journal of biochemistry & cell biology.
[54] Yang Wang,et al. The role of miRNA-29 family in cancer. , 2013, European journal of cell biology.
[55] E. Giovannetti,et al. The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[56] Sheila M. Reynolds,et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. , 2013, Cancer cell.
[57] X. Wan,et al. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer , 2013, Medical Oncology.
[58] Zhongjun Wu,et al. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. , 2013, Cellular signalling.
[59] M. Fiorentino,et al. Loss of miR‐101 expression promotes Wnt/β‐catenin signalling pathway activation and malignancy in colon cancer cells , 2013, The Journal of pathology.
[60] J. Whitsett,et al. Foxm1 transcription factor is required for lung fibrosis and epithelial‐to‐mesenchymal transition , 2013, The EMBO journal.
[61] Sheng Tan,et al. Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. , 2012, Cancer research.
[62] Clare M. Isacke,et al. MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes , 2012, PloS one.
[63] Kai Fu,et al. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. , 2012, Cancer cell.
[64] Zhaojian Liu,et al. MiR‐182 overexpression in tumourigenesis of high‐grade serous ovarian carcinoma , 2012, The Journal of pathology.
[65] Qiang Zhou,et al. TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC , 2012, PloS one.
[66] Manuel A. S. Santos,et al. Lack of microRNA‐101 causes E‐cadherin functional deregulation through EZH2 up‐regulation in intestinal gastric cancer , 2012, The Journal of pathology.
[67] S. Greco,et al. Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152 , 2012, Molecular Cancer.
[68] Christopher G. Hill,et al. The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated , 2012, BMC Medical Genomics.
[69] Y. Toiyama,et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis , 2012, Gut.
[70] S. Persad,et al. Cadherin switch from E‐ to N‐cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail , 2012, The British journal of dermatology.
[71] Yibo Gao,et al. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. , 2012, Biochemical and biophysical research communications.
[72] A. D. Van den Abbeele,et al. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. , 2012, Blood.
[73] Dimitris Anastassiou,et al. A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma , 2012, PloS one.
[74] Min Liu,et al. MicroRNA‐182 targets cAMP‐responsive element‐binding protein 1 and suppresses cell growth in human gastric adenocarcinoma , 2012, The FEBS journal.
[75] Kenichi Sugihara,et al. Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters , 2012, Clinical Cancer Research.
[76] Aamir Ahmad,et al. Recent updates on the role of microRNAs in prostate cancer , 2012, Journal of Hematology & Oncology.
[77] A. Fusco,et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. , 2012, The Journal of clinical endocrinology and metabolism.
[78] Hongbing Shen,et al. A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma , 2012, PloS one.
[79] Y. Mizuguchi,et al. Cooperation of p300 and PCAF in the Control of MicroRNA 200c/141 Transcription and Epithelial Characteristics , 2012, PloS one.
[80] H. Long,et al. Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549 , 2012, Molecules and cells.
[81] Stephen T Warren,et al. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. , 2012, Annual review of pathology.
[82] T. Dønnem,et al. MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer , 2012, PloS one.
[83] H. Ford,et al. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer , 2012, Oncogene.
[84] P. Muti,et al. MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function , 2011, Cell Death and Differentiation.
[85] Xin Lu,et al. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. , 2011, Oncology reports.
[86] P. Vogt. Cyclin Dependent Kinase , 2011 .
[87] F. Luo,et al. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. , 2011, Oncology reports.
[88] Tanja Kunej,et al. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. , 2011, Mutation research.
[89] L. De Cecco,et al. Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients , 2011, Oncotarget.
[90] K. Flaherty,et al. Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer , 2011, Clinical Cancer Research.
[91] K. Hess,et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. , 2011, JAMA.
[92] R. Batchu,et al. MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1 , 2011, Pharmaceutical Research.
[93] B. Bao,et al. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. , 2011, Cancer letters.
[94] Ying Xu,et al. MicroRNA Expression and Regulation in Human Ovarian Carcinoma Cells by Luteinizing Hormone , 2011, PloS one.
[95] B. Davidson,et al. miRNA profiling along tumour progression in ovarian carcinoma , 2011, Journal of cellular and molecular medicine.
[96] Ignacio Varela,et al. Aging and chronic DNA damage response activate a regulatory pathway involving miR‐29 and p53 , 2011, The EMBO journal.
[97] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[98] A. Gill,et al. MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets , 2011, Clinical Cancer Research.
[99] T. Brabletz,et al. p53 spreads out further: suppression of EMT and stemness by activating miR-200c expression , 2011, Cell Research.
[100] T. Luedde,et al. Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.
[101] M. Hung,et al. p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through modulating miRNAs , 2010, Nature Cell Biology.
[102] M. Hung,et al. p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through modulating miRNAs , 2010, Nature Cell Biology.
[103] Zhaoli Chen,et al. microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin* , 2010, The Journal of Biological Chemistry.
[104] X. Wang,et al. The clinical potential of microRNAs , 2010, Journal of hematology & oncology.
[105] F. Ferrari,et al. A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.
[106] Oliver Distler,et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. , 2010, Arthritis and rheumatism.
[107] K. Wiman,et al. Extract from Asteraceae Brachylaena ramiflora induces apoptosis preferentially in mutant p53-expressing human tumor cells. , 2010, Carcinogenesis.
[108] Sun Young Park,et al. Epithelial–mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma , 2010, Cancer science.
[109] F. Wuest,et al. Cyclin-dependent kinase 4/6 (cdk4/6) inhibitors: perspectives in cancer therapy and imaging. , 2010, Mini reviews in medicinal chemistry.
[110] M. Loda,et al. Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation , 2010, Science Signaling.
[111] Ji Wan,et al. Structure and activity of putative intronic miRNA promoters. , 2010, RNA.
[112] X. Estivill,et al. Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease , 2010, European Journal of Human Genetics.
[113] Giuseppe Giannini,et al. MiR‐128 up‐regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[114] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[115] Alexey I Nesvizhskii,et al. Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer* , 2009, Molecular & Cellular Proteomics.
[116] M. Nieto,et al. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.
[117] Zhiwei Wang,et al. miR‐200 Regulates PDGF‐D‐Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells , 2009, Stem cells.
[118] Nicholas J. Wang,et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. , 2009, Cancer research.
[119] F. Sato,et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. , 2009, Gastroenterology.
[120] D. Corcoran,et al. Features of Mammalian microRNA Promoters Emerge from Polymerase II Chromatin Immunoprecipitation Data , 2009, PloS one.
[121] C. Isella,et al. A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis , 2009, Clinical & Experimental Metastasis.
[122] Y. Fujii,et al. microRNA expression profile in undifferentiated gastric cancer. , 2009, International journal of oncology.
[123] Avner Friedman,et al. MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc , 2008, Proceedings of the National Academy of Sciences.
[124] S. Varambally,et al. Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer , 2008, Science.
[125] C. Croce,et al. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. , 2008, Cancer research.
[126] M. F. Shannon,et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. , 2008, Cancer research.
[127] G. Sonenshein,et al. NF‐κB and epithelial to mesenchymal transition of cancer , 2008, Journal of cellular biochemistry.
[128] Artemis G. Hatzigeorgiou,et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.
[129] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[130] J. Mendell. miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.
[131] D. Iliopoulos,et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.
[132] Harrison W. Gabel,et al. MicroRNA‐183 family conservation and ciliated neurosensory organ expression , 2008, Evolution & development.
[133] Birgit Samans,et al. MYCN regulates oncogenic MicroRNAs in neuroblastoma , 2007, International journal of cancer.
[134] T. Golub,et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia , 2007, Proceedings of the National Academy of Sciences.
[135] W. Lukiw,et al. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.
[136] A. Bosserhoff,et al. Expression of Dickkopf genes is strongly reduced in malignant melanoma , 2006, Oncogene.
[137] Barbara A. Murphy,et al. Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma , 2006 .
[138] Raghu Kalluri,et al. The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.
[139] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[140] A. Bosserhoff,et al. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma , 2006, Oncogene.
[141] Yajun Yi,et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. , 2006, Cancer research.
[142] P. Collas,et al. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. , 2005, Molecular biology of the cell.
[143] D. Tarin,et al. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.
[144] D. Tarin,et al. The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.
[145] Lena Smirnova,et al. Regulation of miRNA expression during neural cell specification , 2005, The European journal of neuroscience.
[146] D. Bartel,et al. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. , 2005, RNA.